Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Diabetic Nephropathy
100%
Patient Management
100%
Antihypertensive Agents
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Hyperkalemia
50%
Blood Pressure Control
50%
Calcium Antagonists
50%
Patients with Diabetes
50%
Obese Patients
25%
Risk Reduction
25%
Patient Demographics
25%
Long-term Benefit
25%
Early Diabetic Nephropathy
25%
Treatment Programs
25%
Quality of Life
25%
Weight Reduction
25%
Smoking Cessation Program
25%
Risk for Cardiovascular Diseases
25%
Integrated Treatment
25%
Optimal Treatment
25%
Increased Mortality
25%
Quit Smoking
25%
Decline Rate
25%
Diuretics
25%
Blood Sugar
25%
Alternative Therapy
25%
Mild Hypertension
25%
Should Be Given
25%
National Cholesterol Education Program
25%
Low Protein
25%
Low Cholesterol
25%
Adverse Metabolic Effects
25%
Tight Control
25%
Loop Diuretics
25%
Dietary Control
25%
Disease Risk Factors
25%
Therapy Goals
25%
ACE Inhibition
25%
Vascular Disease Risk
25%
Serum Lipoproteins
25%
Dihydropyridine Calcium Channel Blockers
25%
Advanced Diabetic Nephropathy
25%
Pharmacological Assays
25%
Thiazide Diuretics
25%
Diabetic Diet
25%
Hygienic Measures
25%
On-state Current
25%
Patient Weight
25%
Non-dihydropyridine
25%
Cardiovascular Diseases/complications
25%
Nursing and Health Professions
Dipeptidyl Carboxypeptidase Inhibitor
100%
Antihypertensive Agent
100%
Diabetic Nephropathy
100%
Calcium Antagonist
75%
Patient with Diabetes
50%
Blood Pressure
50%
Pressure Control
50%
Hyperkalemia
50%
Cholesterol
50%
Practice Guideline
25%
Patient Population
25%
Lipoprotein Blood Level
25%
Nicotine Withdrawal
25%
Borderline Hypertension
25%
Loop Diuretic Agent
25%
Smoking Cessation Program
25%
Vascular Disease
25%
Thiazide Diuretic Agent
25%
Diabetic Diet
25%
Cardiovascular Disease
25%
Hypoglycemia
25%
Dihydropyridine
25%
Quality of Life
25%
Side Effect
25%
Education
25%
Medicine and Dentistry
Diabetic Nephropathy
100%
Antihypertensive Agent
100%
ACE Inhibitor
100%
Calcium Antagonist
75%
Blood Pressure
50%
Patient with Diabetes
50%
Pressure Control
50%
Hyperkalemia
50%
Cholesterol
50%
Hypoglycemia
25%
Quality of Life
25%
Cardiovascular Disease
25%
Nicotine Withdrawal
25%
Patient Population
25%
Lipoprotein
25%
Loop Diuretic Agent
25%
Borderline Hypertension
25%
Thiazide Diuretic Agent
25%
Smoking Cessation Program
25%
Vascular Disease
25%
Diabetic Diet
25%
Dihydropyridine
25%
Diuretics
25%
Side Effect
25%
Education
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antihypertensive Agent
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Diabetic Nephropathy
100%
Calcium Antagonist
75%
Hyperkalemia
50%
Cholesterol
50%
Lipoprotein
25%
Borderline Hypertension
25%
Thiazide Diuretic Agent
25%
Loop Diuretic Agent
25%
Hypoglycemia
25%
Vascular Disease
25%
Cardiovascular Disease
25%
Dihydropyridine
25%
Diuretics
25%
Side Effect
25%